For Medical Practitioners - geneType

Your partner in personalised medicine.

It’s well known that prevention is better than cure. And that’s our mantra at geneType. Our tests help develop personalised, preventative health plans for your patients. By integrating your patient’s clinical, familial and genetic data, we deliver a personalised score for their risk of serious conditions. What’s more, we help you interpret your patient’s results in the context of your local guidelines.

For Health Professionals

Take the first step towards personalised, preventative healthcare

Knowing your patients’ personalised risk enables you to develop a health plan with them to reduce their risk of serious disease. Select from the tests below to take the first step to managing your patients’ risk.

Breast Cancer

Find out if your patients are at increased risk of developing breast cancer

Colorectal Cancer

Find out if your patients are at increased risk of developing bowel (colorectal) cancer

Ovarian Cancer

Find out if your patients are at increased risk of developing a ovarian cancer

Prostate Cancer

Find out if your patients are at increased risk of developing a prostate cancer

Coronary Artery Disease

Find out if your patients are at increased risk of developing coronary artery disease

Type 2 Diabetes

Find out if your patients are at increased risk of developing type 2 diabetes

Multi-Risk Test

Find out if your patients are at increased risk of developing a wide range of cancers as well as heart disease and type 2 diabetes

Mental Health

Find out which antidepressant and dose could maximise your patients’ response and minimise side effects

Other Conditions

Find out if your patients are at increased risk of developing conditions such as glaucoma, melanoma or atrial fibrillation

COVID-19 Severity (US only)

Find out if your patients are at risk of developing severe COVID-19 symptoms

One report.
Actionable insights.

GeneType provides a comprehensive risk assessment report that will assist you in developing a personalised health plan for your patients.

Key features of a geneType report include:

  • Quick identification of your patient’s lifetime risk score and 5-, 8- or 10-year risk depending on the condition.
  • Interpretation of these risk scores in the context of your local guideline recommendations to assist with clinical decision making about screening and risk-reducing strategies.
  • A polygenic risk score: this score is based on genetic data and is integrated into the overall risk score. It is typically not included in traditional risk assessment models.

Sample patient report

Scientific Advisory Board

To ensure our tests are of the highest clinical value, geneType has enlisted the experience and expertise of senior scientific and medical leaders from around the world. They help us tailor our tests to reflect the strongest scientific evidence. Together can advance the field. personalised, preventative health solutions.

Professor Jon Emery

Professor Jon Emery

MBBCh MA DPhil FRACGP MRCGP

Research & Education Lead, Primary Care Integration, Victorian Comprehensive Cancer Centre Herman Chair of Primary Care Cancer Research, University of Melbourne

Professor Finlay Macrae AO

Professor Finlay Macrae AO

MBBS, MD, FRACP, FRCP, AGAF MWGO

Principal Fellow and Professor, Department of Medicine, University of Melbourne, and Head of Colorectal Medicine and Genetics, The Royal Melbourne Hospital

Dr. Ora K. Gordon

Dr. Ora K. Gordon

MD, MS, FACMG

Regional Medical Director, Center for Clinical Genetics & Genomics. Clinical Director, PSJH Population Health Genomics Program. Chair, Integrated Network Cancer Program, Professor of Genetics, St John Cancer Institute

 GeneType testing is simple

Step 1

Register as a provider; our team will provide clinical education and other resources as needed.

GeneType will send kits to your clinic to have on hand.

Step 2

Discuss geneType with your patient.

Would geneType help her qualify for additional risk reduction strategies?

Step 3

Complete the Test Requisition form, collect a sample from the patient in the saliva tube provided and return both to geneType.

You will have the option to use a paper requisition, or a secure, HIPAA-compliant portal to complete the ordering process.

Step 4

Leave the rest to us.

GeneType will notify you when your patient’s results are ready.

You will have the option to request a consult with a genetic counsellor,  whether to review your patient’s results and/or to follow-up with your patient, as needed.

Interested in ordering more than one disease? Order geneType Multi-Test.

See individual disease pages for more information about each test.

The Multi-Risk suite of tests is for adults 40-69 years of age. At maximum, a woman would be eligible for 5 diseases in the panel; a man would be eligible for 4. If patient is younger than 40, they may qualify for geneType's breast or colorectal risk assessments only.

Coming soon: melanoma, pancreatic cancer and atrial fibrillation geneType tests. Patient eligibility dependent on personal medical history, age, sex and self-identified race/ethnicity

A genetic counsellor
on your team.

A genetic counsellor is available to help your geneType patients understand the geneType test and interpret their results.

For medical practitioners who order geneType test, you and your patients have the option to speak with a genetic counsellor when their results are ready.

For patients who order through our telehealth partner, they need to speak with our genetic counsellor to have their results released.

Our goal is to support both medical practitioners and patients through this journey. This is not a test-and-forget approach.

If you have technical questions, or questions around a patient’s clinical report, our genetic counsellor and Medical Affairs Team is available to you.

Are you ready to get started with geneType?

The first step is to setup an account to trial geneType at your practice.

Accredited For Compliance With NPAAC Standards And ISO 15189

CLIA Number 99D2023356

Keep up-to-date with our latest advances 

Sign up to our newsletter to stay informed about our latest advances and how these could support your practice.